nuciferine has been researched along with Cancer of Pancreas in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, Y; Wang, Q; Xie, S; Xu, M; Zhang, H; Zhou, L | 1 |
1 other study(ies) available for nuciferine and Cancer of Pancreas
Article | Year |
---|---|
YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to Gemcitabine.
Topics: AMP-Activated Protein Kinases; Animals; Antimetabolites, Antineoplastic; Aporphines; Cell Cycle Proteins; Deoxycytidine; Down-Regulation; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Hydroxymethylglutaryl CoA Reductases; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Phosphorylation; Transcription Factors; Tumor Cells, Cultured | 2019 |